Literature DB >> 11454067

Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine.

I S Leal1, M Flórido, P Andersen, R Appelberg.   

Abstract

We investigated the role of interleukin-6 (IL-6) in the development of the immune response to a subunit vaccine against tuberculosis consisting of the culture filtrate proteins of Mycobacterium tuberculosis emulsified in the adjuvant dimethyldioctadecylammonium bromide (DDA). C57Bl/6 mice immunized with this vaccine developed a strong T helper 1 (Th1) response characterized by an increased production of interferon-gamma (IFN-gamma) secreted by CD4+ T cells. Neutralization of IL-6 during in vivo priming resulted in marked reduction in the ability of T cells to secrete IFN-gamma and IL-2 and to proliferate. IL-6 gene-disrupted mice primed with the vaccine showed a decrease in the number of IFN-gamma-producing cells and an increase in IL-4-secreting cells as compared to control mice. In contrast, neutralization of IL-6 during a boost of the vaccine in previously primed mice did not affect the development of IFN-gamma-producing cells but still increased the number of IL-4-producing cells. Our work shows that IL-6 plays a major role in the priming but not in the later expression of a Th1 response to a tuberculosis vaccine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11454067      PMCID: PMC1783241          DOI: 10.1046/j.1365-2567.2001.01244.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  44 in total

1.  Role of IL-6 in directing the initial immune response to schistosome eggs.

Authors:  A C La Flamme; A S MacDonald; E J Pearce
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 2.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

3.  T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis.

Authors:  P Andersen; D Askgaard; L Ljungqvist; M W Bentzon; I Heron
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

4.  Modeling the impact of global tuberculosis control strategies.

Authors:  C J Murray; J A Salomon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

Review 5.  Cytokines induce the development of functionally heterogeneous T helper cell subsets.

Authors:  A O'Garra
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

6.  Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF.

Authors:  S B Joseph; K T Miner; M Croft
Journal:  Eur J Immunol       Date:  1998-01       Impact factor: 5.532

Review 7.  Lymphocyte responses and cytokines.

Authors:  W E Paul; R A Seder
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

8.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

9.  Recombinant interleukin-6 protects mice against experimental bacterial infection.

Authors:  Z Liu; R J Simpson; C Cheers
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

10.  Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells.

Authors:  M Rincón; J Anguita; T Nakamura; E Fikrig; R A Flavell
Journal:  J Exp Med       Date:  1997-02-03       Impact factor: 14.307

View more
  12 in total

Review 1.  The two faces of IL-6 in the tumor microenvironment.

Authors:  Daniel T Fisher; Michelle M Appenheimer; Sharon S Evans
Journal:  Semin Immunol       Date:  2014-03-03       Impact factor: 11.130

2.  Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation.

Authors:  I S Leal; B Smedegård; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

3.  NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

Review 4.  Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.

Authors:  C Sander; H McShane
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

5.  Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than anti-TNF-α antibody in mice.

Authors:  Masaji Okada; Yoko Kita; Noriko Kanamaru; Satomi Hashimoto; Yasushi Uchiyama; Masahiko Mihara; Yoshikazu Inoue; Yoshiyuki Ohsugi; Tadamitsu Kishimoto; Mitsunori Sakatani
Journal:  Clin Dev Immunol       Date:  2011-02-22

6.  An elucidation of neutrophil functions against Mycobacterium tuberculosis infection.

Authors:  Devin Morris; Thien Nguyen; John Kim; Christine Kassissa; Melissa Khurasany; Jennifer Luong; Sarah Kasko; Shalin Pandya; Michael Chu; Po-Ting Chi; Judy Ly; Minette Lagman; Vishwanath Venketaraman
Journal:  Clin Dev Immunol       Date:  2013-11-07

7.  Neuropeptide Y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice.

Authors:  Evelin Painsipp; Martin J Köfer; Aitak Farzi; Ulrich S Dischinger; Frank Sinner; Herbert Herzog; Peter Holzer
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

8.  Interleukin-6: a potent biomarker of mycobacterial infection.

Authors:  Prati Pal Singh; Amit Goyal
Journal:  Springerplus       Date:  2013-12-21

9.  The toll-like receptor 2/6 ligand MALP-2 reduces the viability of Mycobacterium tuberculosis in murine macrophages.

Authors:  Carla Palma; Elisabetta Iona; Thomas Ebensen; Carlos A Guzman; Antonio Cassone
Journal:  Open Microbiol J       Date:  2009-04-03

10.  IL-6 controls susceptibility to helminth infection by impeding Th2 responsiveness and altering the Treg phenotype in vivo.

Authors:  Katherine A Smith; Rick M Maizels
Journal:  Eur J Immunol       Date:  2013-11-04       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.